Evidence map›Paper›PMID 25312956›Full record

ArticleInfection and immunity2015

Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Steve Oghumu, James C Stock, Sanjay Varikuti, Ran Dong, Cesar Terrazas, Jessica A Edwards, Chad A Rappleye, Ariel Holovatyk, Arlene Sharpe, Abhay R Satoskar

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. The conneXion between sex and immune responses.Nature reviews. Immunology · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Steve OghumuDepartment of Pathology, Ohio State University Medical Center, Columbus, Ohio, USA Department of Oral Biology, Ohio State University College of Dentistry, Columbus, Ohio, USA oghumu.1@osu.edu abhay.satoskar@osumc.edu.
James C StockDepartment of Pathology, Ohio State University Medical Center, Columbus, Ohio, USA.
Sanjay VarikutiDepartment of Pathology, Ohio State University Medical Center, Columbus, Ohio, USA.
Ran DongDepartment of Immunology, University of Washington, Seattle, Washington, USA.
Cesar TerrazasDepartment of Pathology, Ohio State University Medical Center, Columbus, Ohio, USA.
Jessica A EdwardsDepartment of Microbiology, Department of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio, USA.
Chad A RappleyeDepartment of Microbiology, Department of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio, USA.
Ariel HolovatykDepartment of Pathology, Ohio State University Medical Center, Columbus, Ohio, USA.
Arlene SharpeDepartment of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abhay R SatoskarDepartment of Pathology, Ohio State University Medical Center, Columbus, Ohio, USA Department of Microbiology, Department of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio, USA oghumu.1@osu.edu abhay.satoskar@osumc.edu.
The Ohio State University · USThe Ohio State University Wexner Medical Center · USBrigham and Women's Hospital · USUniversity of Washington · US

Funding

Comprehensive Training in Oral &Craniofacial SciencesT32DE014320 · NIDCR · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2001 to 2022
$10.2M
Development of novel therapeutics for a neglected tropical disease leishmaniasisRC4AI092624 · NIAID · OHIO STATE UNIVERSITY · PI KINGHORN, ALAN DOUGLAS, SATOSKAR, ABHAY R · 2010 to 2010
$2.6M
Treatment of cutaneous leishmaniasis using Pentalinon andrieuxii root extractR21AT004160 · NCCIH · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2009 to 2010
$411k
Visualization of CXCR3 allelic usage in vivoR03AI090231 · NIAID · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2010 to 2011
$242k
Treating cutaneous leishmaniasis by radio-frequency induced heat (RFH) therapyR34AI100789 · NIAID · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2012 to 2012
$229k
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIFR03CA164399 · NCI · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2012 to 2013
$153k
NCCIH NIH HHS R21 AT004160NCCIH NIH HHS R21AT004160NCI NIH HHS R03 CA164399NCI NIH HHS R03CA164399NIAID NIH HHS R03 AI090231NIAID NIH HHS R03AI090231NIAID NIH HHS R34 AI100789NIAID NIH HHS R34AI100789NIAID NIH HHS RC4 AI092624NIAID NIH HHS RC4AI092624NIDCR NIH HHS T32 DE014320NIDCR NIH HHS T32DE014320
6 · The paper itself

Abstract

Cutaneous leishmaniasis, caused mainly by Leishmania major, an obligate intracellular parasite, is a disfiguring disease characterized by large skin lesions and is transmitted by a sand fly vector. We previously showed that the chemokine receptor CXCR3 plays a critical role in mediating resistance to cutaneous leishmaniasis caused by Leishmania major. Furthermore, T cells from L. major-susceptible BALB/c but not L. major-resistant C57BL/6 mice fail to efficiently upregulate CXCR3 upon activation. We therefore examined whether transgenic expression of CXCR3 on T cells would enhance resistance to L. major infection in susceptible BALB/c mice. We generated BALB/c and C57BL/6 transgenic mice, which constitutively overexpressed CXCR3 under a CD2 promoter, and then examined the outcomes with L. major infection. Contrary to our hypothesis, transgenic expression of CXCR3 (CXCR3(Tg)) on T cells of BALB/c mice resulted in increased lesion sizes and parasite burdens compared to wild-type (WT) littermates after L. major infection. Restimulated lymph node cells from L. major-infected BALB/c-CXCR3(Tg) mice produced more interleukin-4 (IL-4) and IL-10 and less gamma interferon (IFN-γ). Cells in draining lymph nodes from BALB/c-CXCR3(Tg) mice showed enhanced Th2 and reduced Th1 cell accumulation associated with increased neutrophils and inflammatory monocytes. However, monocytes displayed an immature phenotype which correlated with increased parasite burdens. Interestingly, transgenic expression of CXCR3 on T cells did not impact the outcome of L. major infection in C57BL/6 mice, which mounted a predominantly Th1 response and spontaneously resolved their infection similar to WT littermates. Our findings demonstrate that transgenic expression of CXCR3 on T cells increases susceptibility of BALB/c mice to L. major.

Indexed as

Disease SusceptibilityGene ExpressionAnimalsDisease Models, AnimalFemaleLeishmania majorLeishmaniasis, CutaneousMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicMonocytesParasite LoadReceptors, CXCR3SkinTh2 CellsCxcr3 protein, mouseReceptors, CXCR3

Identifiers

PMID25312956
PMCPMC4288897
OpenAlexW2080346759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.